September 28, 2012 - When the Stryker Rejuvenate and ABG II hip replacement devices were released in 2010, they were heralded as an innovative design that would give implant patients a better, more natural fit, with a durable device life.
However, data from the FDA now suggests that these devices, which have since been recalled, were rushed to market to boost sales without proper testing or warnings to patients about the inherent risks.
Studies have shown that modern metal-on-metal hip implants can experience corrosion and fretting from wear between metal components, sending tiny metal shards into patients’ tissues, bones and bloodstream. With the four-part construction of the Stryker hips, the possibility for wear is heightened.
Studies have shown that the release of titanium, cobalt and chromium metal shavings into the body, the materials used in these hip implants, can cause severe side effects like allergic reactions, bone loss, soft tissue damage, vision or hearing problems and even tumors or cancer.
The Stryker Rejuvenate hip system was approved by FDA through a fast-track procedure called the 510(k) process, which requires little to no testing or warning to consumers. Therefore, the company did not take every precaution to prevent injury to patients.
So far, the U.S. FDA has received more than 60 adverse event reports associated with the Stryker hip implants. However, experts are concerned that thousands more patients may be affected.
On July 6, 2012, Stryker recalled the Rejuvenate and ABG II hip implants. Although they stated they would stop producing and selling the devices, the company has not offered any help or compensation to victims for the necessary removal of the devices or for future medical treatment.
Lawyers are helping those affected file claims. If you or someone you love received a Stryker hip implant, contact us today to speak with a lawyer about your legal options.